Patients relevant in pharmaceutical product trademark decision: Federal Court of Appeal
In Novartis AG v. Biogen Inc., 2024 FC 52, the plaintiff successfully sued for infringement of its registered trademark and passing off for a pharmaceutical preparation for ophthalmology and pharmaceutical preparations...To view the full article, register now.
Already a subscriber? Click here to view full article